Market Overview

BTIG Adds Thomas Shrader, PhD, CFA, as a Managing Director and Senior Biotechnology Equity Research Analyst


announced today that Thomas Shrader, PhD, CFA, has joined
the firm as a Managing Director to provide specialized biotechnology
equity research. Based in New York, he will report into David
Lenchus, Director of Research
at BTIG.

Dr. Shrader will play a pivotal role in the expansion of the firm's
biotechnology research coverage. His expertise spans oncology,
immunology, metabolics and neuroscience. With an established and growing
presence within the biotechnology vertical, BTIG continues to
strategically invest in talent across healthcare research, banking and

"We are thrilled to welcome Tom to BTIG's Research and Strategy team to
bolster our biotechnology research effort," said Mr. Lenchus. "As
an accomplished healthcare research analyst, capital markets
professional and academic, he will provide an insightful research
product that will enlighten our clients and strengthen our highly
responsive biotechnology research platform."

Dr. Shrader has more than 20 years of biotechnology equity research
experience. Prior to BTIG, he was the Vice President of Strategy and
Communications at Intrexon Corporation. Previously, Dr. Shrader was a
Biotechnology Research Analyst at Stifel and Bank of Montreal Capital
Markets. He was also the Director of Strategic Corporate Partnerships at
Yale University, and a Biochemistry faculty member at the Albert
Einstein College of Medicine. Dr. Shrader earned a BA from Johns Hopkins
University, a PhD from Yale University and was a Helen Hay Whitney
Fellow at the Massachusetts Institute of Technology. He is also a CFA

BTIG Research and Strategy provides comprehensive fundamental research
reports and in-depth industry and company observations for clients. Its
sector focus includes consumer, energy, financials, healthcare, real
estate, shipping, and technology, media and telecommunications.

For access to BTIG insights, visit

About BTIG

BTIG is a global financial services firm specializing in institutional
trading, investment banking, research and related brokerage services.
With an extensive global footprint and more than 560 employees, BTIG,
LLC and its affiliates operate out of 17 cities throughout the U.S., and
in Europe, Asia and Australia. BTIG offers execution, expertise and
insights for equities, equity derivatives, ETFs and fixed income,
currency and commodities (futures, commodities, foreign exchange,
interest rates, credit, and convertible and preferred securities). The
firm's core capabilities include global execution, portfolio, electronic
and outsource trading, transition management, investment banking, prime
brokerage, capital introduction, corporate access, research and
strategy, commission management and more.


To learn more about BTIG, visit

View Comments and Join the Discussion!